Your browser doesn't support javascript.
loading
Glucagon-Like Peptide-1 Receptor Agonists-How Safe Are They?
Haider, Shanzay; Lipska, Kasia J.
Affiliation
  • Haider S; Department of Internal Medicine, Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut.
  • Lipska KJ; Department of Internal Medicine, Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut.
JAMA Intern Med ; 182(5): 520-521, 2022 05 01.
Article in En | MEDLINE | ID: mdl-35344015
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptide-1 Receptor Limits: Humans Language: En Journal: JAMA Intern Med Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptide-1 Receptor Limits: Humans Language: En Journal: JAMA Intern Med Year: 2022 Document type: Article Country of publication: United States